PhaseBio Announces Global License of PB1023 to Treat Sarcopenia-Related Diseases to ImmunoForge Biotech Investing
Hemostemix Reaches Milestone in the ACP-01 Phase 2 Critical Limb Ischemia Clinical Trial Biotech Investing
Bellerophon Announces Agreement with FDA on Regulatory Approval Pathway for INOpulse Biotech Investing
Cannara Biotech Appoints, Former CEO of Apotex, Jack Kay as New Board Director Cannabis Investing News
MediPharm Labs Assembles Globally Renowned Experts to Form Scientific Advisory Committee Cannabis Investing News
Life Science Big News Roundup: NanoSphere Products Approved for Sale in California; BriaCell Announces Clinical Trial Collaboration Agreement with Incyte Life Science Investing
Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy Biotech Investing
Celgene and Acceleration Pharma Announce Submission of Luspatercept Biologics License Application to FDA Biotech Investing
